Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ear device may help men last longer without drugs

NCT ID NCT07300774

Symptom relief Sponsor: Bahçeşehir University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a non-invasive device that stimulates the vagus nerve through the ear can help men with premature ejaculation. 102 men received either real or sham stimulation three times a week for 12 weeks. Researchers measured heart rate variability and sexual function to see if the treatment improves control.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Transcutaneous auricular vagus nerve stimulation (taVNS) device
What this could lead to
If it works, this could offer a non-drug, non-invasive option to help men with premature ejaculation improve control and sexual satisfaction.
What could go wrong
This is a small, early-stage study with no phase, and the sham group received no stimulation, so results may not be conclusive. The device may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

102 people

The number who actually took part.

Started

Dec 2025

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 50 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Having a diagnosis of premature ejaculation according to the International Society for Sexual Medicine (ISSM), * Having the same, non-pregnant, sexually active partner for at least 6 months, * Being in a stable, heterosexual relationship, * Suffering from PE and seeking medical treatment. Exclusion Criteria: * Having acquired PE, * History of vagotomy, * Having diabetes, hypertension, cardiovascular disease, * Abnormal neurological examination findings, * Use of drugs that impair heart rate variability (agents, a-receptor agonists or antagonists, tricyclic or serotonergic antidepressants, antihypertensive drugs) * History of pelvic surgery, * Tobacco or alcohol use, * Any organic cause of PE (as assessed by prostatic secretion analysis, thyroid-stimulating hormone); * Having a psychiatric disorder, * Having skin irritation/lesion at the application site, * International Index of Erectile Function score below 26

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Premature ejaculation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

premature ejaculation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Premature ejaculation

Contacts and locations

Locations

  • Bahcesehir University

    Istanbul, Beşiktaş, 34000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.